Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 83
Selected: 0
NCT IDTitle
NCT01662102Rituximab or Zevalin - Efficacy Trial of Therapeutic Alternatives (RoZetta)
NCT02643420SPI-2012 vs Pegfilgrastim in the Management of Neutropenia in Participants With Breast Cancer With Docetaxel and Cyclophosphamide (ADVANCE)
NCT00112060A Study to Assess the Safety and Preliminary Efficacy of PT-523 in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
NCT00129558A Study to Evaluate PT-523 in Patients With Refractory Leukemia
NCT04981704A Study to Evaluate the Effect of Multiple Doses of Itraconazole, Phenytoin, and Paroxetine on the Single-Dose Pharmacokinetics of Poziotinib in Healthy Adult Participants
NCT01587144Safety and Efficacy Study of Lucanthone When Used in Combination With Temozolomide(TMZ) and Radiation to Treat Glioblastoma Multiforme(GBM)
NCT01490723Zevalin-Containing Nonmyeloablative Conditioning for Stem Cell Transplantation (SCT)
NCT02879643Vincristine Sulfate Liposome Injection (Marqibo®) in Combination With UK ALL R3 Induction Chemotherapy
NCT01439347A Phase 3 Study to Evaluate Marqibo® in the Treatment of Subjects ≥ 60 Years Old With Newly Diagnosed ALL
NCT03066206Poziotinib in EGFR Exon 20 Mutant Advanced NSCLC
NCT00865969Belinostat in Relapsed or Refractory Peripheral T-Cell Lymphoma
NCT00427219The Safety and Efficacy of Ozarelix to Treat Men With Lower Urinary Tract Symptoms Due to Enlargement of the Prostate
NCT00088023Safety Study of PT-523 in Cancer Patients to Treat Solid Tumors Including a Preliminary Assessment of Effectiveness
NCT00495079Safety and Efficacy of Marqibo in Relapsed Acute Lymphoblastic Leukemia
NCT00506142Safety and Efficacy of Marqibo in Metastatic Malignant Uveal Melanoma
NCT0005244210-Propargyl-10-Deazaaminopterin in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or Hodgkin's Lymphoma
NCT00998946Study of Pralatrexate to Treat Participants With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma
NCT00322218Study Comparing Zevalin Regimen With no Further Treatment in Patients With Diffuse Large B-cell Lymphoma.
NCT00873119Belinostat, Carboplatin and Paclitaxel (BelCaP) Compared to Carboplatin and Paclitaxel in Patients With Cancer of Unknown Primary
NCT03318939Phase 2 Study of Poziotinib in Participants With NSCLC Having EGFR or HER2 Exon 20 Insertion Mutation
NCT02519270Phase 1, Dose-Escalation Study of IGN002 in NHL Subjects
NCT01317927A Study of Belinostat in Combination With Warfarin in Patients With Solid Tumors or Hematological Malignancies
NCT01129206Pralatrexate and Docetaxel in Treating Patients With Stage IV Esophageal or Gastroesophageal Cancer Who Have Failed Platinum-Based Therapy
NCT00083304Whole Brain Radiation Therapy With Oxygen, With or Without RSR13, in Women With Brain Metastases From Breast Cancer
NCT01478542OPTIMAL>60 / DR. CHOP, Improvement of Therapy of Elderly Patients with CD20+ DLBCL Using Rituximab Optimized and Liposomal Vincristine
NCT00413075Study of Oral PXD101 in Patients With Advanced Solid Tumors or Lymphoma
NCT01811368Zevalin Before Stem Cell Transplant in Treating Patients With Non-Hodgkin Lymphoma
NCT00461591Single Dose Intravesical Apaziquone Postoperative in Patients Undergoing TURBT for Noninvasive Bladder Cancer (SPI-611)
NCT01469221Efficacy and Safety Study of Apaziquone vs. Placebo in Patients With Non-Muscle Invasive Bladder Cancer (NMIBC)
NCT02337478Vincristine Sulfate Liposome in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
NCT03744715A Study to Allow Continued Dosing and/or Follow-up of Patients Who Have Had Previous Exposure to Poziotinib
NCT00055887Chemotherapy and Radiation Therapy With or Without Efaproxiral in Treating Patients With Stage III Non-Small Cell Lung Cancer
NCT00141531Phase II Trial of EOquin in High-risk Superficial Bladder Cancer
NCT02137759MRSI to Predict Response to RT/TMZ ± Belinostat in GBM
NCT02994784Propylene Glycol-Free Melphalan Hydrochloride (Evomela) in AL Amyloidosis Patients
NCT03429101A Study of Poziotinib in Combination With T-DM1 in HER2-Positive Breast Cancer
NCT00765973Topotecan Liposomes Injection for Small Cell Lung Cancer (SCLC), Ovarian Cancer and Other Advanced Solid Tumors
NCT00004202Combination Chemotherapy, Radiation Therapy, and RSR13 in Treating Patients With Stage III Non-small Cell Lung Cancer
NCT01741155Study of SPI-1620 in Combination With Docetaxel Versus Docetaxel Alone for Patients With Non Small-cell Lung Cancer (NSCLC)
NCT01560884Study to Assess the Safety and the Phosphate Binding Capacity of Renazorb
NCT01207765Zevalin for Patients With Incomplete Response to Chemo Prior to Autologous Stem Cell Transplant for Multiple Myeloma
NCT00743184Trial of the Safety and Efficacy of Ozarelix in Participants With Benign Prostatic Hyperplasia (BPH)
NCT02847949A Study of IGN002 for Refractory NHL
NCT04402008Study of Poziotinib in Japanese Patients With NSCLC
NCT00598806Single Dose Intravesical Apaziquone Postoperative in Patients Undergoing TURBT for Noninvasive Bladder Cancer (SPI-612)
NCT00613691A Phase I, Open-label, Ascending Dose Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of the Endothelin B Agonist, SPI-1620, in Patients With Recurrent or Progressive Carcinoma
NCT01549886Phase 2 Study of Zevalin Versus Zevalin and Motexafin Gadolinium in Patients With Rituximab-Refractory Low-grade or Follicular B-cell Non-Hodgkin's Lymphoma
NCT03804515A Mass Balance and Pharmacokinetics Study of 14C-Labeled Poziotinib in Cancer Patients Suitable for Treatment With Poziotinib
NCT04172597A Study of Poziotinib in Patients With Epidermal Growth Factor Receptor (EGFR) or Human Epidermal Growth Factor Receptor 2 (HER2) Activating Mutations in Advanced Malignancies
NCT00656786Safety, Tolerability and Systemic Absorption of Menadione Topical Lotion for Epidermal-Growth-Factor-Receptor (EGFR) Inhibitor-Associated Rash